ArticleBMC cancer2026
Prognostic nutritional index improved the survival prediction of the revised Tokuhashi and Tomita scores for patients with lung cancer spinal metastases.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesLung cancer is currently the leading cause of cancer-related deaths worldwide, with 30%-36% of patients developing spinal metastases. However, the predictive accuracy of commonly used spinal metastasis scoring systems, such as the revised Tokuhashi score and Tomita score, has decreased. This study aims to optimize the revised Tokuhashi and Tomita scores by incorporating new indicators to assist clinicians in making informed treatment decisions.
methodsA retrospective analysis was conducted on 147 patients with lung cancer spinal metastases. Prognostic factors were identified using Cox regression analysis. The predictive performance of different models at the 3-month, 6-month, and 1-year time points was evaluated using receiver operating characteristic (ROC) curves and the DeLong test.
resultsBy incorporating the Prognostic Nutritional Index (PNI) and the presence of non-small cell lung cancer, the optimized P-Tokuhashi and P-Tomita scores were developed. The predictive abilities of P-Tokuhashi at 3 months (AUC = 0.77), 6 months (AUC = 0.71), and 1 year (AUC = 0.74), as well as P-Tomita at 3 months (AUC = 0.74), 6 months (AUC = 0.62), and 1 year (AUC = 0.70), were all superior to the pre-optimization scores. The DeLong test confirmed that the predictive accuracy of the modified scores at 6 months and 1 year was significantly better than that of the original scores (p < 0.05).
conclusionThe new prognostic scoring system for spinal metastasis, which incorporates the PNI and the status of non-small cell lung cancer (NSCLC), provides better prediction of survival in patients with lung cancer spinal metastases, enabling clinicians to select more personalized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.